![]() seqWell seqWell is a company that develops a DNA sequencing platform designed to improve NGS library prep to unlock the full potential of DNA sequencing instruments. | ![]() My Intelligent Machines My Intelligent Machines is a developer of an analytics platform designed to capture key insights, trends, and patterns. | ![]() Naked Biome Naked Biome is a microbiome-based therapeutics company, launching the most advanced therapies to treat and prevent skin disease. | ![]() Intratus Intratus is a clinical-stage life sciences company dedicated to the development of its patented non-invasive drug delivery platform technologies. | ![]() Cell Source Cell Source focuses on developing cell therapy treatments based on the management of immune tolerance. | |
Founding Date | Founding Date 2014 | Founding Date 2016 | Founding Date 2015 | Founding Date N/A | Founding Date 2011 |
Type | Type Private | Type Private | Type Private | Type Private | Type Public |
Tags | |||||
Locations | Locations Beverly, US HQ | Locations Montréal, CA HQ | Locations San Francisco, US HQ | Locations San Diego, US HQ | Locations New York, US HQ New York, US |
Employees | Employees 41 | Employees 3 | Employees 1 | Employees 10 | Employees N/A |
Funding | |||||
Latest funding round | Latest funding round $ 9m (over 6 years ago) | Latest funding round $ 4m (about 5 years ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round N/A |
Total funding raised | Total funding raised $ 11m | Total funding raised $ 6.6m | Total funding raised N/A | Total funding raised N/A | Total funding raised N/A |

My Intelligent Machines is a developer of an analytics platform designed to capture key insights, trends, and patterns.
View company
Naked Biome is a microbiome-based therapeutics company, launching the most advanced therapies to treat and prevent skin disease.
View company
Intratus is a clinical-stage life sciences company dedicated to the development of its patented non-invasive drug delivery platform technologies.
View company
Cell Source focuses on developing cell therapy treatments based on the management of immune tolerance.
View company